Approves New Drug For Treating Mental Illnesses

The FDA has approved the drug Saphris for treating schizophrenia and Bipolar I disorders.

Both are serious mental conditions that have been treated by a variety of drugs that are effective in some, and ineffective in others.

Schizophrenia is a condition where a person will begin to have delusions and hallucinations, such as auditory phenomenon that makes them believe they are hearing voices. They also experience paranoia, such as believing that others are after them, or can read their thoughts.

Bipolar I is a severe condition where the person in question as rapid shifts in mood, energy level, ability to sleep, and other problems, such as lack in appetite, or use of controlled substances. Behavior may also be badly effected during a manic phase, or in times of ‘lows’, where extreme depression makes it hard for the sufferer to cope with everyday life.